Targeting DNA vaccines to myeloid cells using a small peptide
Authors:
Open Access
- 1 October 2014
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 45 (1) , 82-88
Abstract
Targeting DNA vaccines to dendritic cells (DCs) greatly enhances immunity. Although several approaches have been used to target protein Ags to DCs, currently there is no method that targets DNA vaccines directly to DCs. Here, we show that a small peptide derived from the rabies virus glycoprotein fused to protamine residues (RVG‐P) can target DNA to myeloid cells, including DCs, which results in enhanced humoral and T‐cell responses. DCs targeted with a DNA vaccine encoding the immunodominant vaccinia B8R gene via RVG‐P were able to restimulate vaccinia‐specific memory T cells in vitro. Importantly, a single i.v. injection of B8R gene bound to RVG‐P was able to prime a vaccinia‐specific T‐cell response that was able to rapidly clear a subsequent vaccinia challenge in mice. Moreover, delivery of DNA in DCs was enough to induce DC maturation and efficient Ag presentation without the need for adjuvants. Finally, immunization of mice with a DNA‐vaccine encoding West Nile virus (WNV) prM and E proteins via RVG‐P elicited high titers of WNV‐neutralizing Abs that protected mice from lethal WNV challenge. Thus, RVG‐P provides a reagent to target DNA vaccines to myeloid cells and elicit robust T‐cell and humoral immune responses.Keywords
This publication has 32 references indexed in Scilit:
- Recent advances towards the clinical application of DNA vaccines.2013
- Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune responseInternational Immunology, 2012
- Dextran and Protamine-Based Solid Lipid Nanoparticles as Potential Vectors for the Treatment of X-Linked Juvenile RetinoschisisHuman Gene Therapy, 2012
- Single chain antibody fragments for the selective targeting of antigens to dendritic cellsMolecular Immunology, 2005
- Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccinesJournal of Experimental Medicine, 2004
- Immunological Unresponsiveness Characterized by Increased Expression of CD5 on Peripheral T Cells Induced by Dendritic Cells In VivoImmunity, 2004
- In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell VaccinationJournal of Experimental Medicine, 2004
- Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.2003
- Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceJournal of Experimental Medicine, 2002
- West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent AssaysJournal of Virology, 2001